Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHAF1A | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | IGFBP4 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | C9 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | PDS5B | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | NDFIP1 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | FOXI2 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
mRNA | MED4 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | KPNA3 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |